Adherium Overview

  • Founded

  • 2001

Founded
  • Status

  • Public

  • Stock Symbol

  • ADR

Stock Symbol

Adherium General Information

Description

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Contact Information

Website
www.adherium.com
Formerly Known As
Nexus6
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Stock Exchange
ASX
Primary Office
  • PO Box 1149
  • Thornbury, Victoria 3071
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adherium Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.8M 5B 3.76M

Adherium Financials Summary

In Thousands,
USD 		TTM 31-Mar-2023 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 3,057 7,058 15,748 6,776
Revenue 383 299 1,486
EBITDA (8,018) (9,452) (5,677)
Net Income (8,134) (11,210) (7,634)
Total Assets 5,063 12,802 4,616
Total Debt 58 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Adherium Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Adherium‘s full profile, request access.

Request a free trial

Adherium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that addre
Therapeutic Devices
Thornbury, Australia
000.00
000000000 000.00

000000

etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000 000000000
Melbourne, Australia
0 As of 0000
0000
000000000 0000

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000000000 000000000
Amsterdam, Netherlands
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adherium Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Respiri Corporation Melbourne, Australia 0 0000 000000000 0000
0000000 Corporation Amsterdam, Netherlands 00000 00000000
00000000 Corporate Backed or Acquired Huntingdon, United Kingdom 0 0000000000
00000 Venture Capital-Backed Milan, Italy 00 00.000 000000000000 00.000
0000000 (0000000 0 Venture Capital-Backed Mountain View, CA 000 0000 000000000000 0000
You’re viewing 5 of 5 competitors. Get the full list »

Adherium Patents

  • 90

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 25

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Adherium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D983962-S1 Compliance monitor for a medicament infuser Active 08-Jul-2021 00
AU-201814618-S A compliance monitor for a medicament inhaler Active 15-Feb-2018
AU-201814619-S A compliance monitor for a medicament inhaler Active 15-Feb-2018
EP-3658211-A4 Adherence monitoring method and device Active 25-Jul-2017 0000000000 0
ES-2932836-T3 Adhesion control method and device Active 25-Jul-2017 A61J7/0418
To view Adherium’s complete patent history, request access »

Adherium Executive Team (11)

Name Title Board Seat Contact Info
Rick Legleiter Chief Executive Officer
Daniel Kaplon Chief Financial Officer
Geoff Feakes Chief Technical Officer
Rob Turnbull General Manager & Joint Company Secretary
James Ward-Lilley Independent Executive Chairman
You’re viewing 5 of 11 executive team members. Get the full list »

Adherium Board Members (6)

Name Representing Role Since
James Ward-Lilley Self Independent Executive Chairman 000 0000
Jeremy Cook Adherium Board Member 000 0000
Matthew McNamara Self Board Member 000 0000
Maxine Simmons Adherium Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Adherium Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Adherium‘s full profile, request access.

Request a free trial

Adherium ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Health Care IT Services

Subindustry

Rank

Percentile

To view Adherium’s complete esg history, request access »